Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

335 works

Work: CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease

  1. A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

    Martin Jínek, Krzysztof Chylinski, Ines Fonfara +3

    Article20127 citations
    ABI

  2. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

    Valery L. Feigin, Amanuel Alemu Abajobir, Kalkidan Hassen Abate +97

    Article20175 citations
    ABI

  3. Multiplex Genome Engineering Using CRISPR/Cas Systems

    Le Cong, F. Ann Ran, David Cox +8

    Article20134 citations
    ABI

  4. CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes

    Rodolphe Barrangou, Christophe Fremaux, Hélène Deveau +5

    Article20074 citations
    ABI

  5. Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants

    Kira S. Makarova, Yuri I. Wolf, Jaime Iranzo +23

    Review article20194 citations
    ABI

  6. Parkinson's disease

    Bastiaan R. Bloem, Michael S. Okun, Christine Klein

    Review article20214 citations
    ABI

  7. One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering

    Haoyi Wang, Hui Yang, Chikdu Shivalila +4

    Article20133 citations
    ABI

  8. Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity

    Stephen K. Van Den Eeden

    Article20033 citations
    ABI

  9. 53BP1, BRCA1, and the Choice between Recombination and End Joining at DNA Double-Strand Breaks

    James M. Daley, Patrick Sung

    Review article20143 citations
    ABI

  10. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product

    Yoshizumi Ishino, Hideo Shinagawa, K Makino +2

    Article19873 citations
    ABI

  11. Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression

    Lei S. Qi, Matthew H. Larson, Luke A. Gilbert +4

    Article20133 citations
    ABI

  12. Delivering CRISPR: a review of the challenges and approaches

    Christopher A. Lino, Jason C. Harper, James P. Carney +1

    Review article20183 citations
    ABI

  13. DNA targeting specificity of RNA-guided Cas9 nucleases

    Patrick D. Hsu, David A. Scott, Joshua A. Weinstein +11

    Article20132 citations
    ABI

  14. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III

    Elitza Deltcheva, Krzysztof Chylinski, Cynthia M. Sharma +6

    Article20112 citations
    ABI

  15. A Guild of 45 CRISPR-Associated (Cas) Protein Families and Multiple CRISPR/Cas Subtypes Exist in Prokaryotic Genomes

    Daniel H. Haft, Jeremy Selengut, Emmanuel F. Mongodin +1

    Article20052 citations
    ABI

  16. Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9

    Taeyoung Koo, Jungjoon Lee, Jin‐Soo Kim

    Review article20152 citations
    ABI

  17. Genome engineering using the CRISPR-Cas9 system

    F. Ann Ran, Patrick D. Hsu, Jason Wright +3

    Article20132 citations
    ABI

  18. Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial

    Kevin Fitzgerald, Maria Frank-Kamenetsky, Svetlana Shulga‐Morskaya +17

    Article20132 citations
    ABI

  19. RNA-Guided Human Genome Engineering via Cas9

    Prashant Mali, Luhan Yang, Kevin M. Esvelt +5

    Article20132 citations
    ABI

  20. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

    Yanfang Fu, Jennifer A Foden, Cyd Khayter +4

    Article20132 citations
    ABI

  21. Electrospun biomimetic nanocomposite nanofibers of hydroxyapatite/chitosan for bone tissue engineering

    Yanzhong Zhang, Jayarama Reddy Venugopal, A El-Turki +3

    Article20082 citations
    ABI

  22. The blood-brain barrier: Bottleneck in brain drug development

    William M. Pardridge

    Review article20042 citations
    ABI

  23. Viral vectors: a look back and ahead on gene transfer technology.

    Laura Vannucci, Michele Lai, Flavia Chiuppesi +2

    Article20132 citations
    ABI

  24. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

    Daniel G. Healy, Mario Falchi, Sean S. O’Sullivan +22

    Article20082 citations
    ABI

  25. Parkinson's disease: clinical features and diagnosis

    Joseph Jankovic

    Review article20082 citations
    ABI